AJOONI vs MGEL: Stock Comparison

Ajooni Biotech Limited vs Mangalam Global Enterprise Limited

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

Mangalam Global Enterprise Limited is the larger company by market capitalisation. Ajooni Biotech Limited shows faster revenue growth, lower leverage and a higher net margin, while Mangalam Global Enterprise Limited shows a higher ROE, a higher dividend yield and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Ajooni Biotech Limited and Mangalam Global Enterprise Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, AJOONI is more favourable on 5 of 11 scored metrics and MGEL on 6These counts are context-free and are not an overall rating.

Key Differences

Market Cap
MGEL is the larger company
₹533 Cr vs ₹70 Cr
EPS
MGEL has higher earnings per share
₹1.16 vs ₹0.25
Dividend Yield
MGEL has a higher dividend yield
0.06% vs 0%
Revenue Growth (TTM YoY)
AJOONI has faster revenue growth
103.3% vs 24.92%
EPS Growth (TTM YoY)
MGEL has faster EPS growth
-32.83% vs -44.4%
Qtr Sales Growth
AJOONI has stronger quarterly sales growth
107% vs 25.4%
Qtr Profit Growth
MGEL has stronger quarterly profit growth
12.1% vs -38.3%
ROE
MGEL has a higher ROE
18.23% vs 4.82%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricAJOONIMGEL
SectorFast Moving Consumer GoodsFast Moving Consumer Goods
IndustryAnimal FeedOther Agricultural Products

Price

MetricAJOONIMGEL
Live Price₹4.03₹15.2
Day Change2.03%1.06%
Volume6.6 L5.78 L
52-Week High₹5.94₹18.4
52-Week Low₹3.4₹9.53
Distance from 52W High-32.15%-17.39%

Valuation

MetricAJOONIMGEL
Market Cap₹70 Cr₹533 Cr
P/E Ratio11.81x
P/B Ratio2.15x
EPS₹0.25₹1.16
Book Value₹4.81₹6.12
Dividend Yield0%0.06%

Growth

MetricAJOONIMGEL
Revenue Growth (TTM YoY)103.3%24.92%
EPS Growth (TTM YoY)-44.4%-32.83%
Qtr Sales Growth107%25.4%
Qtr Profit Growth-38.3%12.1%

Profitability & Leverage

MetricAJOONIMGEL
ROE4.82%18.23%
ROCE6.49%16.8%
Net Margin2.34%1.34%
Operating Margin3.43%2.52%
Debt to Equity0.19x0.87x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricAJOONIMGEL
Promoter Holding26.89%72.38% 0.92 pp
FII Holding0%0.18% 0.01 pp
DII Holding0%0%
Public Holding73.11%27.44% 0.93 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Ajooni Biotech Limited and Mangalam Global Enterprise Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.